Abstract
Background:
Anxiety, although as common as depression, has received less attention and is often undetected and undertreated.
Objective:
To determine the current prevalence, impairment, and comorbidity of anxiety disorders in primary care and to evaluate a brief measure for detecting these disorders.
Design:
Criterion-standard study performed between November 2004 and June 2005.
Setting:
15 U.S. primary care clinics.
Participants:
965 randomly sampled patients from consecutive clinic patients who completed a self-report questionnaire and agreed to a follow-up telephone interview.
Measurements:
7-item anxiety measure (Generalized Anxiety Disorder [GAD]-7 scale) in the clinic, followed by a telephone-administered, structured psychiatric interview by a mental health professional who was blinded to the GAD-7 results. Functional status (Medical Outcomes Study Short Form-20), depressive and somatic symptoms, and self-reported disability days and physician visits were also assessed.
Results:
Of the 965 patients, 19.5% (95% CI, 17.0% to 22.1%) had at least 1 anxiety disorder, 8.6% (CI, 6.9% to 10.6%) had posttraumatic stress disorder, 7.6% (CI, 5.9% to 9.4%) had a generalized anxiety disorder, 6.8% (CI, 5.3% to 8.6%) had a panic disorder, and 6.2% (CI, 4.7% to 7.9%) had a social anxiety disorder. Each disorder was associated with substantial impairment that increased significantly (P < 0.001) as the number of anxiety disorders increased. Many patients (41%) with an anxiety disorder reported no current treatment. Receiver-operating characteristic curve analysis showed that both the GAD-7 scale and its 2 core items (GAD-2) performed well (area under the curve, 0.80 to 0.91) as screening tools for all 4 anxiety disorders.
Limitation:
The study included a nonrandom sample of selected primary care practices.
Conclusions:
Anxiety disorders are prevalent, disabling, and often untreated in primary care. A 2-item screening test may enhance detection.
References
- 1.
Spitzer RL ,Williams JB ,Kroenke K ,Linzer M ,deGruy FV ,Hahn SR ,et al . Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272:1749-56. [PMID: 7966923] CrossrefMedlineGoogle Scholar - 2.
Leon AC ,Olfson M ,Broadhead WE ,Barrett JE ,Blacklow RS ,Keller MB ,et al . Prevalence of mental disorders in primary care. Implications for screening. Arch Fam Med. 1995;4:857-61. [PMID: 7551133] CrossrefMedlineGoogle Scholar - 3.
Ormel J ,VonKorff M ,Ustun TB ,Pini S ,Korten A ,Oldehinkel T . Common mental disorders and disability across cultures. Results from the WHO Collaborative Study on Psychological Problems in General Health Care. JAMA. 1994;272:1741-8. [PMID: 7966922] CrossrefMedlineGoogle Scholar - 4.
Olfson M ,Shea S ,Feder A ,Fuentes M ,Nomura Y ,Gameroff M ,et al . Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med. 2000;9:876-83. [PMID: 11031395] CrossrefMedlineGoogle Scholar - 5.
Ansseau M ,Dierick M ,Buntinkx F ,Cnockaert P ,De Smedt J ,Van Den Haute M ,et al . High prevalence of mental disorders in primary care. J Affect Disord. 2004;78:49-55. [PMID: 14672796] CrossrefMedlineGoogle Scholar - 6.
Spitzer RL ,Kroenke K ,Linzer M ,Hahn SR ,Williams JB ,deGruy FV ,et al . Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995;274:1511-7. [PMID: 7474219] CrossrefMedlineGoogle Scholar - 7.
Olfson M ,Fireman B ,Weissman MM ,Leon AC ,Sheehan DV ,Kathol RG ,et al . Mental disorders and disability among patients in a primary care group practice. Am J Psychiatry. 1997;154:1734-40. [PMID: 9396954] CrossrefMedlineGoogle Scholar - 8.
Schonfeld WH ,Verboncoeur CJ ,Fifer SK ,Lipschutz RC ,Lubeck DP ,Buesching DP . The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Affect Disord. 1997;43:105-19. [PMID: 9165380] CrossrefMedlineGoogle Scholar - 9.
Mendlowicz MV ,Stein MB . Quality of life in individuals with anxiety disorders. Am J Psychiatry. 2000;157:669-82. [PMID: 10784456] CrossrefMedlineGoogle Scholar - 10.
Sanderson K ,Andrews G . Prevalence and severity of mental health-related disability and relationship to diagnosis. Psychiatr Serv. 2002;53:80-6. [PMID: 11773654] CrossrefMedlineGoogle Scholar - 11.
Alonso J ,Angermeyer MC ,Bernert S ,Bruffaerts R ,Brugha TS ,Bryson H ,et al . Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;:38-46. [PMID: 15128386] MedlineGoogle Scholar - 12.
Marciniak MD ,Lage MJ ,Dunayevich E ,Russell JM ,Bowman L ,Landbloom RP ,et al . The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety. 2005;21:178-84. [PMID: 16075454] CrossrefMedlineGoogle Scholar - 13.
Rapaport MH ,Clary C ,Fayyad R ,Endicott J . Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 2005;162:1171-8. [PMID: 15930066] CrossrefMedlineGoogle Scholar - 14.
Stein MB ,Roy-Byrne PP ,Craske MG ,Bystritsky A ,Sullivan G ,Pyne JM ,et al . Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care. 2005;43:1164-70. [PMID: 16299426] CrossrefMedlineGoogle Scholar - 15.
Regier DA ,Boyd JH ,Burke JD ,Rae DS ,Myers JK ,Kramer M ,et al . One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites. Arch Gen Psychiatry. 1988;45:977-86. [PMID: 3263101] CrossrefMedlineGoogle Scholar - 16.
Greenberg PE ,Sisitsky T ,Kessler RC ,Finkelstein SN ,Berndt ER ,Davidson JR ,et al . The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427-35. [PMID: 10453795] CrossrefMedlineGoogle Scholar - 17.
Issakidis C ,Sanderson K ,Corry J ,Andrews G ,Lapsley H . Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychol Med. 2004;34:19-35. [PMID: 14971624] CrossrefMedlineGoogle Scholar - 18.
Roy-Byrne PP ,Wagner A . Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry. 2004;65 Suppl 13 20-6. [PMID: 15384933] MedlineGoogle Scholar - 19.
Wittchen HU ,Kessler RC ,Beesdo K ,Krause P ,Höfler M ,Hoyer J . Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry. 2002;63 Suppl 8 24-34. [PMID: 12044105] MedlineGoogle Scholar - 20.
Roy-Byrne PP ,Stein MB ,Russo J ,Mercier E ,Thomas R ,McQuaid J ,et al . Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. J Clin Psychiatry. 1999;60:492-9. [PMID: 10453807] CrossrefMedlineGoogle Scholar - 21.
Gross R ,Olfson M ,Gameroff MJ ,Shea S ,Feder A ,Lantigua R ,et al . Social anxiety disorder in primary care. Gen Hosp Psychiatry. 2005;27:161-8. [PMID: 15882762] CrossrefMedlineGoogle Scholar - 22.
Gillock KL ,Zayfert C ,Hegel MT ,Ferguson RJ . Posttraumatic stress disorder in primary care: prevalence and relationships with physical symptoms and medical utilization. Gen Hosp Psychiatry. 2005;27:392-9. [PMID: 16271653] CrossrefMedlineGoogle Scholar - 23.
Magruder KM ,Frueh BC ,Knapp RG ,Davis L ,Hamner MB ,Martin RH ,et al . Prevalence of posttraumatic stress disorder in Veterans Affairs primary care clinics. Gen Hosp Psychiatry. 2005;27:169-79. [PMID: 15882763] CrossrefMedlineGoogle Scholar - 24.
Kessler D ,Lloyd K ,Lewis G ,Gray DP . Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ. 1999;318:436-9. [PMID: 9974461] CrossrefMedlineGoogle Scholar - 25.
Löwe B ,Gräfe K ,Zipfel S ,Spitzer RL ,Herrmann-Lingen C ,Witte S ,et al . Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians’ diagnosis. J Psychosom Res. 2003;55:515-9. [PMID: 14642981] CrossrefMedlineGoogle Scholar - 26.
Spitzer RL ,Kroenke K ,Williams JB ,Löwe B . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092-7. [PMID: 16717171] CrossrefMedlineGoogle Scholar - 27.
Stewart AL ,Hays RD ,Ware JE . The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988;26:724-35. [PMID: 3393032] CrossrefMedlineGoogle Scholar - 28.
Derogatis LR ,Lipman RS ,Rickels K ,Uhlenhuth EH ,Covi L . The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions. Mod Probl Pharmacopsychiatry. 1974;7:79-110. [PMID: 4607278] CrossrefMedlineGoogle Scholar - 29.
Kroenke K ,Spitzer RL . The PHQ-9: a new depression and diagnostic severity measure. Psychiatr Ann. 2002;32:509-21. CrossrefGoogle Scholar - 30.
Connor KM ,Kobak KA ,Churchill LE ,Katzelnick D ,Davidson JR . Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. Depress Anxiety. 2001;14:137-40. [PMID: 11668666] CrossrefMedlineGoogle Scholar - 31.
Kroenke K ,Spitzer RL ,Williams JB . The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258-66. [PMID: 11914441] CrossrefMedlineGoogle Scholar - 32.
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, VA: American Psychiatric; 1994. Google Scholar - 33.
First MB ,Spitzer RL ,Gibbon M ,Williams JBW . Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinician’s Version. Arlington, VA: American Psychiatric; 1996. Google Scholar - 34.
Aneshensel CS ,Frerichs RR ,Clark VA ,Yokopenic PA . Measuring depression in the community: a comparison of telephone and personal interviews. Public Opin Q. 1982;46:110-21. [PMID: 10256145] CrossrefMedlineGoogle Scholar - 35.
Wells KB ,Burnam MA ,Leake B ,Robins LN . Agreement between face-to-face and telephone-administered versions of the depression section of the NIMH Diagnostic Interview Schedule. J Psychiatr Res. 1988;22:207-20. [PMID: 3225790] CrossrefMedlineGoogle Scholar - 36.
Simon GE ,Revicki D ,VonKorff M . Telephone assessment of depression severity. J Psychiatr Res. 1993;27:247-52. [PMID: 8295157] CrossrefMedlineGoogle Scholar - 37.
Means-Christensen A ,Sherbourne CD ,Roy-Byrne P ,Craske MG ,Bystritsky A ,Stein MB . The Composite International Diagnostic Interview (CIDI-Auto): problems and remedies for diagnosing panic disorder and social phobia. Int J Methods Psychiatr Res. 2003;12:167-81. [PMID: 14657973] CrossrefMedlineGoogle Scholar - 38.
Rief W ,Nanke A ,Klaiberg A ,Braehler E . Base rates for panic and depression according to the Brief Patient Health Questionnaire: a population-based study. J Affect Disord. 2004;82:271-6. [PMID: 15488257] CrossrefMedlineGoogle Scholar - 39.
Kroenke K ,Spitzer RL ,Williams JB . The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258-66. [PMID: 11914441] CrossrefMedlineGoogle Scholar - 40.
DeLong ER ,DeLong DM ,Clarke-Pearson DL . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-45. [PMID: 3203132] CrossrefMedlineGoogle Scholar - 41.
Pasacreta JV . Measuring depression.. In: Frank-Stromborg M, Olsen SJ, eds. Instruments for Clinical Health Care Research. 2nd ed. Sudbury, MA: Jones & Bartlett; 1997:342-60. Google Scholar - 42.
Kazis LE ,Anderson JJ ,Meenan RF . Effect sizes for interpreting changes in health status. Med Care. 1989;27:S178-89. [PMID: 2646488] CrossrefMedlineGoogle Scholar - 43.
Mulrow CD ,Williams JW ,Gerety MB ,Ramirez G ,Montiel OM ,Kerber C . Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122:913-21. [PMID: 7755226] LinkGoogle Scholar - 44.
Williams JW ,Pignone M ,Ramirez G ,Perez Stellato C . Identifying depression in primary care: a literature synthesis of case-finding instruments. Gen Hosp Psychiatry. 2002;24:225-37. [PMID: 12100833] CrossrefMedlineGoogle Scholar - 45.
Kroenke K ,Spitzer RL ,Williams JB ,Linzer M ,Hahn SR ,deGruy FV ,et al . Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774-9. [PMID: 7987511] CrossrefMedlineGoogle Scholar - 46.
Simon G ,Gater R ,Kisely S ,Piccinelli M . Somatic symptoms of distress: an international primary care study. Psychosom Med. 1996;58:481-8. [PMID: 8902899] CrossrefMedlineGoogle Scholar - 47.
Kroenke K . The interface between physical and psychological symptoms. Prim Care Companion J Clin Psychiatry. 2003;5Suppl 7 11-8. Google Scholar - 48.
Kroenke K ,Jackson JL ,Chamberlin J . Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med. 1997;103:339-47. [PMID: 9375700] CrossrefMedlineGoogle Scholar - 49.
Simon GE ,VonKorff M ,Piccinelli M ,Fullerton C ,Ormel J . An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329-35. [PMID: 10536124] CrossrefMedlineGoogle Scholar - 50.
Sherbourne CD ,Wells KB ,Meredith LS ,Jackson CA ,Camp P . Comorbid anxiety disorder and the functioning and well-being of chronically ill patients of general medical providers. Arch Gen Psychiatry. 1996;53:889-95. [PMID: 8857865] CrossrefMedlineGoogle Scholar - 51.
Marcus SC ,Olfson M ,Pincus HA ,Shear MK ,Zarin DA . Self-reported anxiety, general medical conditions, and disability bed days. Am J Psychiatry. 1997;154:1766-8. [PMID: 9396962] CrossrefMedlineGoogle Scholar - 52.
Sareen J ,Cox BJ ,Clara I ,Asmundson GJ . The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey. Depress Anxiety. 2005;21:193-202. [PMID: 16075453] CrossrefMedlineGoogle Scholar - 53.
Weiller E ,Bisserbe JC ,Maier W ,Lecrubier Y . Prevalence and recognition of anxiety syndromes in five European primary care settings: a report from the WHO study on Psychological Problems in General Health Care. Br J Psychiatry. 1998;173Suppl 34 18-23. CrossrefGoogle Scholar - 54.
Andrews G ,Henderson S ,Hall W . Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145-53. [PMID: 11157427] CrossrefMedlineGoogle Scholar - 55.
Young AS ,Klap R ,Sherbourne CD ,Wells KB . The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61. [PMID: 11146758] CrossrefMedlineGoogle Scholar - 56.
Edlund MJ ,Unützer J ,Wells KB . Clinician screening and treatment of alcohol, drug, and mental problems in primary care: results from healthcare for communities. Med Care. 2004;42:1158-66. [PMID: 15550795] CrossrefMedlineGoogle Scholar - 57.
Wang PS ,Demler O ,Kessler RC . Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92:92-8. [PMID: 11772769] CrossrefMedlineGoogle Scholar - 58.
Barlow DH ,Allen LB ,Choate ML . Toward a unified treatment for emotional disorders. Behav Ther. 2004;35:205-30. CrossrefGoogle Scholar - 59.
O’Malley PG ,Jackson JL ,Santoro J ,Tomkins G ,Balden E ,Kroenke K . Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract. 1999;48:980-90. [PMID: 10628579] MedlineGoogle Scholar - 60.
Kroenke K ,Swindle R . Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom. 2000;69:205-15. [PMID: 10867588] CrossrefMedlineGoogle Scholar - 61.
Jackson JL ,O’Malley PG ,Kroenke K . Antidepressants and cognitive-behavioral therapy for symptom syndromes. CNS Spectr. 2006;11:212-22. [PMID: 16575378] CrossrefMedlineGoogle Scholar - 62.
Barsky AJ ,Orav EJ ,Bates DW . Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry. 2005;62:903-10. [PMID: 16061768] CrossrefMedlineGoogle Scholar - 63.
Kroenke K ,Spitzer RL ,Williams JB . The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41:1284-92. [PMID: 14583691] CrossrefMedlineGoogle Scholar - 64.
Löwe B ,Kroenke K ,Gräfe K . Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58:163-71. [PMID: 15820844] CrossrefMedlineGoogle Scholar - 65.
Whooley MA ,Avins AL ,Miranda J ,Browner WS . Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12:439-45. [PMID: 9229283] CrossrefMedlineGoogle Scholar - 66.
Hing E ,Cherry DK ,Woodwell DA . National Ambulatory Medical Care Survey: 2004 summary. Adv Data. 2006;:1-33. [PMID: 16841616] MedlineGoogle Scholar - 67.
Cleary PD ,Jette AM . The validity of self-reported physician utilization measures. Med Care. 1984;22:796-803. [PMID: 6492908] CrossrefMedlineGoogle Scholar - 68.
Von Korff M ,Ustun TB ,Ormel J ,Kaplan I ,Simon GE . Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol. 1996;49:297-303. [PMID: 8676177] CrossrefMedlineGoogle Scholar - 69.
Kessler RC ,Ormel J ,Demler O ,Stang PE . Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey. J Occup Environ Med. 2003;45:1257-66. [PMID: 14665811] CrossrefMedlineGoogle Scholar - 70.
Buist-Bouwman MA ,de Graaf R ,Vollebergh WA ,Ormel J . Comorbidity of physical and mental disorders and the effect on work-loss days. Acta Psychiatr Scand. 2005;111:436-43. [PMID: 15877710] CrossrefMedlineGoogle Scholar
Author, Article, and Disclosure Information
Kurt Kroenke,
From Regenstrief Institute for Health Care and Indiana University, Indianapolis, Indiana; New York State Psychiatric Institute and Columbia University, New York, New York; and University of Heidelberg, Heidelberg, Germany.
Acknowledgments: The authors thank Monika Mussell, PhD, and Dieter Schellberg, PhD, University of Heidelberg, Heidelberg, Germany, for their invaluable assistance in some data analyses.
Grant Support: Pfizer Inc.
Disclosures: Consultancies: K. Kroenke (Eli Lilly Inc., Pfizer Inc.), J.B.W. Williams (Eli Lilly Inc., GlaxoSmithKline); Honoraria: K. Kroenke (Eli Lilly Inc., Wyeth); Grants received: K. Kroenke (Eli Lilly Inc., Pfizer Inc., Wyeth), R.L. Spitzer (Pfizer Inc.), J.B.W. Williams (Pfizer Inc.), B. Löwe (Pfizer Inc.).
Corresponding Author: Kurt Kroenke, MD, Regenstrief Institute, 1050 Wishard Boulevard, Indianapolis, IN 46202; e-mail, kkroenke@regenstrief.
Current Author Addresses: Dr. Kroenke: Regenstrief Institute for Health Care, 1050 Wishard Boulevard, Indianapolis, IN 46202.
Drs. Spitzer and Williams: New York State Psychiatric Institute, Unit 60, 1051 Riverside Drive, New York, NY 10533.
Dr. Monahan: Division of Biostatistics, Department of Medicine, Indiana University, 1050 Wishard Boulevard, RG4 101, Indianapolis, IN 46202.
Dr. Löwe: Klinik für Psychosomatische und Allgemeine Klinische Medizin, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
Author Contributions: Conception and design: K. Kroenke, R.L. Spitzer, J.B.W. Williams, B. Löwe.
Analysis and interpretation of the data: K. Kroenke, R.L. Spitzer, J.B.W. Williams, P.O. Monahan, B. Löwe.
Drafting of the article: K. Kroenke.
Critical revision of the article for important intellectual content: K. Kroenke, R.L. Spitzer, P.O. Monahan, B. Löwe.
Final approval of the article: K. Kroenke, R.L. Spitzer, J.B.W. Williams, P.O. Manahan, B. Löwe.
Statistical expertise: K. Kroenke, R.L. Spitzer, P.O. Monahan.
Obtaining of funding: K. Kroenke, R.L. Spitzer, B. Löwe.
Collection and assembly of data: J.B.W. Williams.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.